FAS and neoplasm: In recent study, it has been reported that overweight prostate cancer patients tend to have germline single nucleotide polymorphisms (SNPs) in the FAS gene and FAS tumor expression, suggesting FAS might play the key role in poor outcome in obese prostate cancer patients [21].